查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1386270

神经生物标记物市场报告：2030 年趋势、预测与竞争分析

Neurological Biomarker Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

神经生物标记的趋势和预测

到 2030 年，全球神经生物标记市场预计将达到 147 亿美元，2024 年至 2030 年年复合成长率为 11.7%。该市场的主要驱动力是液体活检的日益普及、人工智慧 (AI) 在神经生物标记开发中的使用增加以及个人化医疗需求的不断增长。全球神经生物标记市场的未来充满希望，医院/医院实验室、独立临床诊断中心和研究机构市场都有机会。

神经生物标誌物市场洞察

Lucintel 预测，由于神经系统疾病的盛行率不断增加，蛋白质体学将在预测期内达到最高成长。

在这个市场中，医院和医院实验室将见证最高的成长，因为它们被认为是神经系统疾病诊断服务的主要提供者。

由于阿兹海默症、帕金森氏症和多发性硬化症等神经系统疾病的高盛行率，以及该地区医疗保健支出的增加，预计北美在预测期内仍将是最大的地区。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2. 未来哪个细分市场成长较快？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

目录

第1章执行摘要

第2章全球神经生物标记市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第3章2018-2030年市场趋势及预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球神经生物标记市场趋势（2018-2023）与预测（2024-2030）
  • 按类型分類的全球神经生物标记市场
    • 基因组
    • 蛋白质体学
    • 代谢组学
    • 影像
    • 其他的
  • 全球神经生物标记市场（按应用）
    • 阿兹海默症
    • 帕金森氏症
    • 多发性硬化症
    • 泛自闭症障碍
    • 其他的
  • 按最终用途分類的全球神经生物标记市场
    • 医院和医院实验室
    • 独立临床诊断中心
    • 研究机构等

第4章2018-2030年分地区市场趋势及预测分析

  • 全球神经生物标记市场（按地区）
  • 北美神经生物标记市场
  • 欧洲神经生物标记市场
  • 亚太神经生物标记市场
  • 其他区域神经生物标记市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 按类型分類的全球神经生物标记市场成长机会
    • 全球神经生物标记物市场成长机会（按应用）
    • 全球神经生物标记物市场成长机会（依最终用途）
    • 按地区分類的全球神经生物标记市场成长机会
  • 全球神经生物标记市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 全球神经生物标记市场的产能扩张
    • 全球神经生物标记市场的合併、收购和合资企业
    • 认证和许可

第7章主要企业概况

  • Abbott
  • Thermo Fisher Scientific
  • Bio-Rad Laboratories
  • Merck
  • Johnson & Johnson Services
  • BANYAN BIOMARKERS
  • Myriad Genetics
简介目录

Neurological Biomarker Trends and Forecast

The future of the global neurological biomarker market looks promising with opportunities in the hospital & hospital laboratory, independent clinical diagnostic center, and research organizations markets. The global neurological biomarker market is expected to reach an estimated $14.7 billion by 2030 with a CAGR of 11.7% from 2024 to 2030. The major drivers for this market are growing adoption of liquid biopsy, increasing utilization of artificial intelligence (AI) in neurological biomarker development, and rising demand for personalized medicine.

A more than 150-page report is developed to help in your business decisions.

Neurological Biomarker by Segment

The study includes a forecast for the global neurological biomarker by type, application, end use, and region.

Neurological Biomarker Market by Type [Shipment Analysis by Value from 2018 to 2030]:

  • Genomic
  • Proteomic
  • Metabolomic
  • Imaging
  • Others

Neurological Biomarker Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Alzheimer'S Disease
  • Parkinson'S Disease
  • Multiple Sclerosis
  • Autism Spectrum Disorder
  • Others

Neurological Biomarker Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Hospital & Hospital Laboratories
  • Independent Clinical Diagnostic Centers
  • Research Organizations and Others

Neurological Biomarker Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Neurological Biomarker Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies neurological biomarker companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the neurological biomarker companies profiled in this report include-

  • Abbott
  • Thermo Fisher Scientific
  • Bio-Rad Laboratories
  • Merck
  • Johnson & Johnson Services
  • Banyan Biomarkers
  • Myriad Genetics

Neurological Biomarker Market Insights

Lucintel forecasts that proteomic is expected to witness highest growth over the forecast period due to increasing prevalence of neurological diseases.

Within this market, hospitals and hospital laboratories will witness the highest growth as they are considered as a primary providers of diagnostic services for neurological disorders.

North America will remain the largest region over the forecast period due to high prevalence of neurological disorders, such as alzheimer's disease, parkinson's disease, and multiple sclerosis and rising healthcare expenditure in the region.

Features of the Global Neurological Biomarker Market

Market Size Estimates: Neurological biomarker market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Neurological biomarker market size by type, application, end use, and region in terms of value ($B).

Regional Analysis: Neurological biomarker market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different type, application, end use, and regions for the neurological biomarker market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the neurological biomarker market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the neurological biomarker market size?

Answer: The global neurological biomarker market is expected to reach an estimated $14.7 billion by 2030.

Q.2 What is the growth forecast for neurological biomarker market?

Answer: The global neurological biomarker market is expected to grow with a CAGR of 11.7% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the neurological biomarker market?

Answer: The major drivers for this market are growing adoption of liquid biopsy, increasing utilization of artificial intelligence (AI) in neurological biomarker development, and rising demand for personalized medicine.

Q4. What are the major segments for neurological biomarker market?

Answer: The future of the neurological biomarker market looks promising with opportunities in the hospital & hospital laboratory, independent clinical diagnostic center, and research organizations markets.

Q5. Who are the key neurological biomarker market companies?

Answer: Some of the key neurological biomarker companies are as follows:

  • Abbott
  • Thermo Fisher Scientific
  • Bio-Rad Laboratories
  • Merck
  • Johnson & Johnson Services
  • Banyan Biomarkers
  • Myriad Genetics

Q6. Which neurological biomarker market segment will be the largest in future?

Answer: Lucintel forecasts that proteomic is expected to witness highest growth over the forecast period due to increasing prevalence of neurological diseases.

Q7. In neurological biomarker market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to high prevalence of neurological disorders, such as alzheimer's disease, parkinson's disease, and multiple sclerosis and rising healthcare expenditure in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the neurological biomarker market by type (genomic, proteomic, metabolomic, imaging, and others), application (alzheimer's disease, parkinson's disease, multiple sclerosis, autism spectrum disorder, and others), end use (hospital & hospital laboratories, independent clinical diagnostic centers, and research organizations and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Neurological Biomarker Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Neurological Biomarker Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Neurological Biomarker Market by Type
    • 3.3.1: Genomic
    • 3.3.2: Proteomic
    • 3.3.3: Metabolomic
    • 3.3.4: Imaging
    • 3.3.5: Others
  • 3.4: Global Neurological Biomarker Market by Application
    • 3.4.1: Alzheimer's Disease
    • 3.4.2: Parkinson's Disease
    • 3.4.3: Multiple Sclerosis
    • 3.4.4: Autism Spectrum Disorder
    • 3.4.5: Others
  • 3.5: Global Neurological Biomarker Market by End Use
    • 3.5.1: Hospital & Hospital Laboratories
    • 3.5.2: Independent Clinical Diagnostic Centers
    • 3.5.3: Research Organizations and Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Neurological Biomarker Market by Region
  • 4.2: North American Neurological Biomarker Market
    • 4.2.2: North American Neurological Biomarker Market by End Use: Hospital & Hospital Laboratories, Independent Clinical Diagnostic Centers, and Research Organizations and Others
  • 4.3: European Neurological Biomarker Market
    • 4.3.1: European Neurological Biomarker Market by Type: Genomic, Proteomic, Metabolomic, Imaging, and Others
    • 4.3.2: European Neurological Biomarker Market by End Use: Hospital & Hospital Laboratories, Independent Clinical Diagnostic Centers, and Research Organizations and Others
  • 4.4: APAC Neurological Biomarker Market
    • 4.4.1: APAC Neurological Biomarker Market by Type: Genomic, Proteomic, Metabolomic, Imaging, and Others
    • 4.4.2: APAC Neurological Biomarker Market by End Use: Hospital & Hospital Laboratories, Independent Clinical Diagnostic Centers, and Research Organizations and Others
  • 4.5: ROW Neurological Biomarker Market
    • 4.5.1: ROW Neurological Biomarker Market by Type: Genomic, Proteomic, Metabolomic, Imaging, and Others
    • 4.5.2: ROW Neurological Biomarker Market by End Use: Hospital & Hospital Laboratories, Independent Clinical Diagnostic Centers, and Research Organizations and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Neurological Biomarker Market by Type
    • 6.1.2: Growth Opportunities for the Global Neurological Biomarker Market by Application
    • 6.1.3: Growth Opportunities for the Global Neurological Biomarker Market by End Use
    • 6.1.4: Growth Opportunities for the Global Neurological Biomarker Market by Region
  • 6.2: Emerging Trends in the Global Neurological Biomarker Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Neurological Biomarker Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Neurological Biomarker Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Abbott
  • 7.2: Thermo Fisher Scientific
  • 7.3: Bio-Rad Laboratories
  • 7.4: Merck
  • 7.5: Johnson & Johnson Services
  • 7.6: BANYAN BIOMARKERS
  • 7.7: Myriad Genetics